Charlotte Jane Mitchell
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charlotte Jane Mitchell.
Angewandte Chemie | 2011
Robin B. Bedford; Mairi F. Haddow; Charlotte Jane Mitchell; Ruth L. Webster
Eine einfache Pd-katalysierte ortho-selektive Bromierung und Chlorierung von Aniliden gelingt unter aeroben Bedingungen bei Raumtemperatur, wenn N-Halogensuccinimide (NXS) in Gegenwart von p-Toluolsulfonsaure (PTSA) eingesetzt werden. Der orthopalladierte PTSA-Komplex ist nicht nur katalytisch aktiv, sondern geht auch einen reduktiven Prozess unter Bildung eines ungewohnlichen PdI-PdII-Tetramers ein (siehe Struktur; Pd grun, O rot, S gelb, C grau).
Chemical Communications | 2010
Robin B. Bedford; Charlotte Jane Mitchell; Ruth L. Webster
Solvent-free reaction conditions facilitate a range of aromatic C-H functionalisations that traditionally require acidic or disfavoured solvents. These reactions include selective ortho- and meta-arylation of aryl carbamates and anilides and selective halogenation reactions.
Bioorganic & Medicinal Chemistry Letters | 2008
J. Nicole Hamblin; Tony D. Angell; Stuart P. Ballantine; Caroline Mary Cook; Anthony William James Cooper; John Dawson; Christopher J. Delves; Paul Jones; Mika Kristian Lindvall; Fiona S. Lucas; Charlotte Jane Mitchell; Margarete Neu; Lisa E. Ranshaw; Yemisi E. Solanke; Don O. Somers; Joanne Wiseman
Optimisation of a high-throughput screening hit resulted in the discovery of 4-(substituted amino)-1-alkyl-pyrazolo[3,4-b]pyridine-5-carboxamides as potent and selective inhibitors of Phosphodiesterase 4 (PDE4). Herein, we describe early SAR studies around this novel template highlighting preferred substituents and rationalization of SAR through X-ray crystal structures of analogues bound to the PDE4 active site. Pyrazolopyridine 20a was found to be a potent and selective PDE4 inhibitor which also inhibits LPS induced TNF-alpha production from isolated human peripheral blood mononuclear cells and has an encouraging rat PK profile suitable for oral dosing.
Dalton Transactions | 2010
Robin B. Bedford; Jens U. Engelhart; Mairi F. Haddow; Charlotte Jane Mitchell; Ruth L. Webster
The solvent-free, palladium-catalysed reaction of anilides with CuCl(2) in the presence or absence of copper acetate yields ortho-chlorinated anilides in good to excellent yields, even on a large scale (100 mmol). By contrast, the equivalent reactions with copper bromide, either solvent free or in 1,2-dichloroethane, in the presence or absence of palladium, under air or inert conditions, gave the products of simple electrophilic bromination. Mechanistic studies highlighted the involvement of palladacyclic intermediates, one of which was characterised crystallographically, which undergo subsequent reaction with copper(II) chloride to yield the chlorinated anilide products.
Bioorganic & Medicinal Chemistry Letters | 2010
Charlotte Jane Mitchell; Stuart P. Ballantine; Diane Mary Coe; Caroline Mary Cook; Christopher J. Delves; Mike D. Dowle; Chris D. Edlin; J. Nicole Hamblin; Stuart Holman; Martin R. Johnson; Paul Jones; Sue E. Keeling; Michael Kranz; Mika Kristian Lindvall; Fiona S. Lucas; Margarete Neu; Yemisi E. Solanke; Don O. Somers; Naimisha Trivedi; Joanne Wiseman
Following the discovery of 4-(substituted amino)-1-alkyl-pyrazolo[3,4-b]pyridine-5-carboxamides as potent and selective phosphodiesterase 4B inhibitors, [Hamblin, J. N.; Angell, T.; Ballentine, S., et al. Bioorg. Med. Chem. Lett.2008, 18, 4237] the SAR of the 5-position was investigated further. A range of substituted heterocycles showed good potencies against PDE4. Optimisation using X-ray crystallography and computational modelling led to the discovery of 16, with sub-nM inhibition of LPS-induced TNF-α production from isolated human peripheral blood mononuclear cells.
Organic and Biomolecular Chemistry | 2009
Robin B. Bedford; Ruth L. Webster; Charlotte Jane Mitchell
Archive | 2011
Ian Robert Baldwin; Kenneth David Down; Paul Faulder; Simon Gaines; Julie Nicole Hamblin; Zoe Alicia Harrison; Katherine Louise Jones; Paul Jones; Suzanne Elaine Keeling; Joelle Le; Christopher James Lunniss; Charlotte Jane Mitchell; Nigel James Parr; Timothy John Ritchie; John Edward Robinson; Juliet Kay Simpson; Christian Alan Paul Smethurst; Yoshiaki Washio
Archive | 2010
Julie Nicole Hamblin; Paul Spencer Jones; Suzanne Elaine Keeling; Joelle Le; Charlotte Jane Mitchell; Nigel James Parr
Archive | 2012
Julie Nicole Hamblin; Paul Spencer Jones; Suzanne Elaine Keeling; Joelle Le; Charlotte Jane Mitchell; Nigel James Parr; Robert David Willacy
Bioorganic & Medicinal Chemistry Letters | 2006
Nigel S. Watson; David W. Brown; Matthew Campbell; Chuen Chan; Laiq Chaudry; Rebecca Fenwick; J. Nicole Hamblin; Claudine Haslam; Henry A. Kelly; N. Paul King; Cynthia L. Kurtis; Andrew R. Leach; Gary R. Manchee; Andrew M. Mason; Charlotte Jane Mitchell; Champa Patel; Vipulkumar Kantibhai Patel; Stefan Senger; Gita P. Shah; Helen E. Weston; Caroline Whitworth; Robert J. Young